Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study

BackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology,...

Full description

Bibliographic Details
Main Authors: Xiangyuan Sun, Xiaocui Zou, Boting Zhou, Tao Yin, Ping Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/full
_version_ 1797685478250512384
author Xiangyuan Sun
Xiangyuan Sun
Xiaocui Zou
Boting Zhou
Boting Zhou
Tao Yin
Tao Yin
Ping Wang
Ping Wang
author_facet Xiangyuan Sun
Xiangyuan Sun
Xiaocui Zou
Boting Zhou
Boting Zhou
Tao Yin
Tao Yin
Ping Wang
Ping Wang
author_sort Xiangyuan Sun
collection DOAJ
description BackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology, risk factors, and outcomes of CRKP BSIs and CRKP non-BSIs.MethodsWe conducted a retrospective study of patients infected with CRKP in the ICU from January 2012 to December 2020. Clinical characteristics and outcomes were compared between CRKP BSIs and CRKP non-BSIs. Predictors associated with 28-day all-cause mortality in CRKP-infected patients were also evaluated.Results326 patients infected with CRKP were enrolled, including 96 patients with CRKP BSIs and 230 with CRKP non-BSIs. The rates of CRKP BSIs in CRKP infections were generally raised from 2012 (12.50%) to 2020 (45.76%). Multivariate logistic analysis indicated that the use of carbapenems within the prior 90 days was an independent risk factor for CRKP BSIs (p = 0.019). Compared to CRKP non-BSIs, CRKP isolates in the CRKP BSI group were found to be non-susceptible to more tested carbapenems (p = 0.001). Moreover, the CRKP BSI group exhibited a higher mortality rate (p = 0.036). The non-susceptibility of CRKP isolates to more tested carbapenems (p = 0.025), a high SOFA score (p = 0.000), and the use of antifungal drugs within the prior 90 days (p = 0.018) were significant factors for 28-day all-cause mortality in CRKP-infected patients.ConclusionThe proportion of CRKP BSI increased progressively in CRKP-infected patients over 9 years. The use of carbapenems within the prior 90 days was an independent risk factor for the development of CRKP BSIs. The non-susceptibility of CRKP isolates to more tested carbapenems and a higher mortality rate were found in the CRKP BSI group.
first_indexed 2024-03-12T00:44:46Z
format Article
id doaj.art-0e1e320c98154746a607a50df72a66af
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-12T00:44:46Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-0e1e320c98154746a607a50df72a66af2023-09-14T18:02:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-09-011010.3389/fmed.2023.12307211230721Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective studyXiangyuan Sun0Xiangyuan Sun1Xiaocui Zou2Boting Zhou3Boting Zhou4Tao Yin5Tao Yin6Ping Wang7Ping Wang8Department of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaDepartment of Pharmacy, Lixian People’s Hospital, Lixian, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pharmacy, Xiangya Hospital, Central South University, Changsha Hunan, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaBackgroundBloodstream infections (BSIs) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) have received much attention. However, few studies have identified risk factors for CRKP BSIs in comparison to CRKP non-bloodstream infections (non-BSIs). This study aimed to compare the epidemiology, risk factors, and outcomes of CRKP BSIs and CRKP non-BSIs.MethodsWe conducted a retrospective study of patients infected with CRKP in the ICU from January 2012 to December 2020. Clinical characteristics and outcomes were compared between CRKP BSIs and CRKP non-BSIs. Predictors associated with 28-day all-cause mortality in CRKP-infected patients were also evaluated.Results326 patients infected with CRKP were enrolled, including 96 patients with CRKP BSIs and 230 with CRKP non-BSIs. The rates of CRKP BSIs in CRKP infections were generally raised from 2012 (12.50%) to 2020 (45.76%). Multivariate logistic analysis indicated that the use of carbapenems within the prior 90 days was an independent risk factor for CRKP BSIs (p = 0.019). Compared to CRKP non-BSIs, CRKP isolates in the CRKP BSI group were found to be non-susceptible to more tested carbapenems (p = 0.001). Moreover, the CRKP BSI group exhibited a higher mortality rate (p = 0.036). The non-susceptibility of CRKP isolates to more tested carbapenems (p = 0.025), a high SOFA score (p = 0.000), and the use of antifungal drugs within the prior 90 days (p = 0.018) were significant factors for 28-day all-cause mortality in CRKP-infected patients.ConclusionThe proportion of CRKP BSI increased progressively in CRKP-infected patients over 9 years. The use of carbapenems within the prior 90 days was an independent risk factor for the development of CRKP BSIs. The non-susceptibility of CRKP isolates to more tested carbapenems and a higher mortality rate were found in the CRKP BSI group.https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/fullCarbapenem resistanceKlebsiella pneumoniaebloodstream infectionnon-bloodstream infectionintensive care unit
spellingShingle Xiangyuan Sun
Xiangyuan Sun
Xiaocui Zou
Boting Zhou
Boting Zhou
Tao Yin
Tao Yin
Ping Wang
Ping Wang
Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
Frontiers in Medicine
Carbapenem resistance
Klebsiella pneumoniae
bloodstream infection
non-bloodstream infection
intensive care unit
title Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
title_full Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
title_fullStr Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
title_full_unstemmed Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
title_short Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
title_sort comparison of bloodstream and non bloodstream infections caused by carbapenem resistant klebsiella pneumoniae in the intensive care unit a 9 year respective study
topic Carbapenem resistance
Klebsiella pneumoniae
bloodstream infection
non-bloodstream infection
intensive care unit
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1230721/full
work_keys_str_mv AT xiangyuansun comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT xiangyuansun comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT xiaocuizou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT botingzhou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT botingzhou comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT taoyin comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT taoyin comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT pingwang comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy
AT pingwang comparisonofbloodstreamandnonbloodstreaminfectionscausedbycarbapenemresistantklebsiellapneumoniaeintheintensivecareunita9yearrespectivestudy